MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1. To consider and approve the standalone unaudited financial results for the quarter ended on 31st December 2021 along with Limited Review Reports. 2. Any other business with the permission of the Chairman.